Text Size

Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies

Nguyen Q.D., Merrill P.T., Sepah Y.J., Ibrahim M.A., Banker A., Leonardi A., Chernock M., Mudumba S., Do D.V.


  • 2018
  • Ophthalmology
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Categories

    Preclinical development

  • Affiliations

    Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, United States; Department of Ophthalmology, Rush University Medical Center, Chicago, IL, United States; Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, United States; Banker's Retina Clinic and Laser Center, Navrangpura, Ahmedabad, India; Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy; Santen, Inc., Emeryville, CA, United States; Ocular Imaging Research and Reading Center (OIRRC), Menlo Park, CA, United States

Related Publications

Efficacy and Safety of Low-Concentration Atropine in Slowing Myopia Progression in Children in Japan: The Randomized, Double-Blind Phase II/III ORANGE Study

Ohno-Matsui K., Igarashi-Yokoi T., Migita Y., Yamakawa Y, on behalf of the ORANGE study investigators


Awareness of Myopia Associated Complications and Perspectives on Myopia Management Among Parents of Children with Myopia in France and the UK

Hafizi R., Deferne N., Paudel N., Angerer A., Hsieh H.-T.


Cutamesine (SA4503) Protects Retinal Ganglion Cells in an Ocular Hypertension Model of Glaucoma Determined Using Detection of Apoptosing Retinal Cells Technology and RBPMS Cell Marker

Sharif N.A., Takashi O., Taniguchi T., Sasaoka M., Guo L., Choi S., Luong V., Cordeiro M.F.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022